Evolve Biologics Inc., launched as the plasma products and technology division of Therapure Biopharma, is a leader in the development and commercialization of plasma-derived therapeutics. Evolve is currently in the process of commercializing an exciting and innovative portfolio of product candidates, including IVIG and Albumin, both of which are in advanced stages of regulatory approval in the US and Canada.